ReviewBiosafety and health2026
Containment of antimicrobial resistance for strengthening global public health security: Biorisk management perspectives.
Review in Biosafety and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antibiotic Resistance: From the Bench to Patients, 2.0.Antibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobials have been hugely successful in improving health outcomes. However, its positive impact is threatened by worldwide increase of antimicrobial resistance (AMR). Use, misuse and overuse are the drivers of AMR. Antimicrobials are used in healthcare, poultry farming and agriculture, horticulture, food production and feed additives, growth promoters, and in aquaculture. Other major drivers are poor infection control, environmental contamination, and geographical movement. AMR is a global public health concern. Without mitigation and remedial actions, estimated mortality attributed to AMR could rise to 10 million globally by 2050. AMR is a natural phenomenon. The use of antimicrobials creates a reservoir of resistance that exists within the ecosystem. AMR is a One Health concern. To contain AMR, a collaborative effort of all the relevant sectors, working locally, nationally, and globally, is the way to attain optimal One Health. Poor biorisk management measures in healthcare, poultry farms, agriculture and aquaculture, can lead to introduction and spread of infections and AMR. Wastewater is the reservoir of pathogens capable of transmitting infections, and at the same time, releasing antimicrobial, AMR genes into the environment, contaminating the entire biosphere. Although injudicious use of antimicrobials is mostly blamed for the failure of containment, improper waste management, likely plays a greater role, superseding the crisis, created by other means. AMR originates in, and passes vertically and horizontally through, microorganisms, among the ecosystems. Thus, the implementation of required biorisk management measures will ensure the protection from unintentional release of pathogens; protect the animals and the humans from zoonosis and reverse zoonosis; protect the environment and the entire biosphere from the spread of contaminants; protect the biological agent itself from loss, theft, misuse, diversion, or intentional release. Together with implemented biorisk management measures globally, judicious use of antimicrobials may lead to the total containment of AMR, strengthening global public health security.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.